SCHEMBL19862143

SCHEMBL19862143

C1=Cc2ccc(-c3cc(-c4ccccc4)nc(-c4ccc(-c5cccnc5)nc4)n3)cc2C2(c3ccccc31)c1ccccc1-c1cc3c(cc12)oc1ccccc13

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP1A2 P05177 1/20 0.34
GAA P10253 1/20 0.34
CYP2C19 P33261 1/20 0.34
HDAC6 Q9UBN7 1/20 0.33
DHODH Q02127 1/20 0.32
KDM4E B2RXH2 2/20 0.31
NPC1 O15118 2/20 0.31
MAPT P10636 2/20 0.31
RAB9A P51151 2/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
PDK2 Q15119 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.30
CYP19A1 P11511 1/20 0.30
GBA1 P04062 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19862150 0.98 GAA (0.34) CYP3A4CYP2C9CYP1A2GAACYP2C19
SCHEMBL19862198 0.98 CYP3A4 (0.34) CYP3A4CYP2C9CYP1A2GAACYP2C19
SCHEMBL19862193 0.98 CYP1A2 (0.34) CYP3A4CYP2C9CYP1A2GAACYP2C19
SCHEMBL19862180 0.96 GAA (0.35) CYP3A4CYP2C9CYP1A2GAACYP2C19
SCHEMBL19862200 0.95 CYP1A2 (0.34) CYP3A4CYP2C9CYP1A2GAACYP2C19
SCHEMBL19862166 0.94 GAA (0.36) CYP3A4CYP2C9CYP1A2GAACYP2C19
SCHEMBL19862161 0.94 CYP1A2 (0.36) CYP3A4CYP2C9CYP1A2GAACYP2C19
SCHEMBL19862190 0.92 DHODH (0.36) CYP3A4CYP2C9CYP1A2GAACYP2C19
SCHEMBL19862191 0.92 DHODH (0.36) CYP3A4CYP2C9CYP1A2GAACYP2C19
SCHEMBL19862163 0.92 DHODH (0.37) CYP3A4CYP2C9CYP1A2GAACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10454039-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-10-22 US disclosed
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-15 US disclosed
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME ORC3, AOX1, RCOR3 CYP3A4 216/4885CYP2C9 80/4885CYP1A2 298/4885
US-10454039-B2 Compound and organic electronic device using the same ORC3, AOX1, RCOR3 CYP3A4 216/4885CYP2C9 80/4885CYP1A2 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.